Valvular Heart Disease Long-Term Survival After Aortic Valve Replacement Among High-Risk Elderly Patients in the United States Insights From the Society of Thoracic Surgeons Adult Cardiac Surgery

Valvular Heart Disease Long-Term Survival After Aortic Valve Replacement Among High-Risk Elderly Patients in the United States

High-risk Coronary Artery Bypass Grafting and Mitral Valve Replacement in a HIV Positive Patient

Certain subsets of high-risk mitral valve patients are not suitable candidates for transcatheter therapies. The objective of this report is to present a young patient with combined mitral valve and coronary artery disease to illustrate these challenges.In this report, we present a 47-year-old man with longstanding HIV infection who was referred with severe mitral regurgitation (MR) and profound...

مقایسه اندازه دریچه آئورت مصنوعی نصب شده با قطر رینگ دریچه آئورت به طریقه اکوکاردیوگرافی دو بعدی بمنظور پیش بینی اندازه دریچه مصنوعی آئورت قبل از عمل جراحی

In recent socio-economic state it is not possible to have different sets of prosthetic cardiac valves available in the operating room before open-heart surgery for valvular replacement. In this study the diameter of the aortic valve ring measured in 2-D echocardiography was compared with the size of the aortic prosthetic valves implanted for the patients with aortic valvular disease. The purpos...

Inter-Operative Time between Neurosurgery and Cardiac Surgery for Native Valve Endocarditis

Introduction: Infective endocarditis is well known to produce neurologic complications from septic emboli, which mandates a multidisciplinary approach between neurosurgery and cardiac surgery. However, literature is not clear as to the optimal interval length between neurosurgery and cardiac surgery.Presentation of Cases: The first case involves a 60-year-old woman with significant past medical...

Transcatheter Aortic Valve Replacement: A Review Article

Transcatheter aortic valve replacement (TAVR) is a novel therapeutic intervention for the replacement of severely stenotic aortic valves in high-risk patients for standard surgical procedures. Since the initial PARTNER trial results, use of TAVR has been on the rise each year. New delivery methods and different valves have been developed and modified in order to promote the minimally invasive p...